Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Personalised Anti-CD20 Retreatment in Multiple Sclerosis: Precision Medicine or Precision Pharmacology?
Investigating the association between grey matter hypoperfusion and atrophy in multiple sclerosis using arterial spin labelling.
One-Year Clinical and Radiographic Outcomes of Alveolar Bone Regeneration Using 3D-Printed β-Tricalcium Phosphate Biomaterials for Single Implant Rehabilitation: A Retrospective Study.
Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden.
Response to correspondence: Should autologous HSCT be a first-line option in highly active MS? No.
Optic Neuropathy in Neurosarcoidosis Masquerading as Optic Nerve Sheath Meningioma: A Case Report and Literature Review.
Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy May Manifest as Recurrent Guillain-Barré Syndrome of a Severe Refractory Case.
mRNA therapeutics for restoring immune tolerance in autoimmune diseases.
Multi-glial inhibitory plasticity in epilepsy and sleep: implications for post-traumatic epileptogenesis.
Association between fatigue and functional status among patients with multiple sclerosis.
Neuromodulatory effects of N-acetyl-L-leucine in a human induced neuronal cell culture system.
Longitudinal Neurofilament Light Chain Z-Score Dynamics: Bridging the Gap Between Research and Routine Monitoring in Multiple Sclerosis.
Regional normal-appearing white matter metabolic profiles and cognition in early relapsing-remitting multiple sclerosis: a multi-voxel proton magnetic resonance spectroscopy study.
Therapeutic targeting of G protein-coupled receptors in central nervous system disorders: from novel mechanisms to precision pharmacology.
FDA-approved Dimethyl Fumarate Targets Thioredoxin Reductase to Induce Apoptosis in Triple-Negative Breast Cancer.
Clinical characteristics, management and outcomes in immune checkpoint inhibitor-induced central nervous system demyelinating disease.
Assessing the Role of Patient-Physician Sex Concordance on Diagnostic Accuracy in Primary Care: A Randomized Factorial Survey Experiment.
Pathobiology-guided diagnostic advances, biomarker discovery, and emerging therapeutic strategies in progressive multiple sclerosis.
"Low-Positive" MOG-IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis.
Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.
Implementation of a pilot online educational program to identify paramagnetic rim lesions.
Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.
Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990-2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023.
When myelin breaks, tau aggregates - a new perspective on Alzheimer's disease.
Emotion recognition in multiple sclerosis: The influence of processing speed and cognitive reserve.
Pages
« first
‹ previous
…
1072
1073
1074
1075
1076
1077
1078
1079
1080
…
next ›
last »